BDBM450951 US10676469, Compound 214::US11124504, Cpd. No. 214

SMILES CCc1cc(C#N)c2nc(N3CC[C@H](C[C@H]3C)N[C@H]3CCOC3)c(-c3nc(C)no3)c(C)c2c1

InChI Key InChIKey=ADANVLMPMJWXOD-LPTQZCDUSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 450951   

TargetMu-type opioid receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM450951(US10676469, Compound 214 | US11124504, Cpd. No. 21...)
Affinity DataIC50: >100nMAssay Description:The purpose of this assay is to confirm the potency and selectivity of compounds synthesized to be OPRK1 Antagonists. This assay monitors the OPRMu1 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM450951(US10676469, Compound 214 | US11124504, Cpd. No. 21...)
Affinity DataIC50:  5.5nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent